The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Open accessAbstract
The outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, has emerged in China in December 2019 and rapidly spread to more than 196 countries worldwide. The physiopathology of human SARS-CoV-2 has not been completely understood, but its pathogenesis has been linked to a disproportionate response of the immune system. Just as described for SARS and MERS, an uncontrolled systemic inflammatory response, known as cytokine release syndrome (CRS) was observed in severe COVID-19 patients. It results from the release by immune and non-immune effector cells of substantial amounts of pro-inflammatory cytokines and appears to contribute to SARS-CoV-2 pulmonary inflammation and extensive lung damage. In addition, hyper-coagulation and thrombosis resulted from the important release of pro-inflammatory cytokines contribute to the lethality of subjects severely infected with SARS-CoV-2. It is therefore essential to have a deep understanding of the various cytokines involved in this exacerbated immune response, and that could be targeted by potential immunological treatments. The aim of this review was to gather the current knowledge about the role of pro-inflammatory cytokines, namely IL-1β, IL-6, IL-8, IL-17 and TNFα in SARS-CoV-2 CRS, the probable causes and clinical outcomes of this phenomenon in severe cases of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 1×
“The principal sources of this cytokine are macrophages, monocytes, dendritic cells, B lymphocytes, neutrophils and synovial fibroblasts [38].”
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science · doi:10.1126/science.abd4570 · Cited by 2,229
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061 · cited 1×
“To infect cells, envelope spike proteins of SARS-CoV and MERS-CoV bind to two different types of receptors, respectively ACE2 (found in cells of the heart, kidneys, testes and also broadly expressed in the lungs, liver, intestine, and brain) [101] and DPP4 (widely expressed on epithelial cells, in the kidney, alveoli,…”
BackgroundThrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
Molecular immune pathogenesis and diagnosis of COVID-19
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,721
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J.-Q., Du, P., Wei, D., Zhang, Y., Sun, X.-X., Gong, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00426-x · Cited by 1,593
Neutrophil extracellular traps in COVID-19
Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J. A., Blair, C. N., Weber, A., Barnes, B. J., Egeblad, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138999 · Cited by 1,582
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, T., Zhang, F., Lui, G. C. Y., Yeoh, Y. K., Li, A. Y. L., Zhan, H., Wan, Y., Chung, A. C. K., Cheung, C. P., Chen, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.048 · Cited by 1,537
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 1×
“This indicated the link between IL-17 and inflammation through IL-6 production and the IL-8-induced neutrophils activation [47].”
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Jose, R. J., & Manuel, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,240
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Han, H., Yang, L., Liu, R., Liu, F., Wu, K.-L., Li, J., Liu, X.-H., & Zhu, C.-L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0188 · Cited by 1,223
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Herold, T., Jurinovic, V., Arnreich, C., Lipworth, B. J., Hellmuth, J. C., von Bergwelt-Baildon, M., Klein, M., & Weinberger, T. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.008 · Cited by 1,161
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Devaux, C. A., Rolain, J.-M., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099
MERS, SARS and other coronaviruses as causes of pneumonia
Yin, Y., & Wunderink, R. G. (2018) · Respirology · doi:10.1111/resp.13196 · Cited by 1,095
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094 · cited 1×
“excessive release of these two chemokines led to the recruitment of neutrophils, monocytes, and T cells in the lungs [55].”
BackgroundXiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1747363 · Cited by 1,076 · cited 2×
“tients, an important apoptosis gene, TP53, was highly expressed in PBMCs, indicating that apoptosis may be responsible of T lymphocytes number reduction [20].”
BackgroundClinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Chua, R. L., Lukassen, S., Trump, S., Hennig, B. P., Wendisch, D., Pott, F., Debnath, O., Thürmann, L., Kurth, F., Völker, M. T., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0602-4 · Cited by 1,035
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Tassan Din, C., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 970
Expanding roles for CD4+ T cells in immunity to viruses
Swain, S. L., McKinstry, K. K., & Strutt, T. M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3152 · Cited by 956
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Yang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.027 · Cited by 872
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission
Tian, Y., Rong, L., Nian, W., & He, Y. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15731 · Cited by 832
COVID-19: what has been learned and to be learned about the novel coronavirus disease
Yi, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45134 · Cited by 832
Fu, Y., Cheng, Y., & Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00207-4 · Cited by 788
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Wu, D., & Yang, X. O. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.005 · Cited by 785
Toniati, P., Piva, S., Cattalini, M., Garrafa, E., Regola, F., Castelli, F., Franceschini, F., Airò, P., Bazzani, C., Beindorf, E.-A., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102568 · Cited by 751
Xu, J., Zhao, S., Teng, T., Abdalla, A. E., Zhu, W., Xie, L., Wang, Y., & Guo, X. (2020) · Viruses · doi:10.3390/v12020244 · Cited by 683
Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19
Dolhnikoff, M., Duarte‐Neto, A. N., de Almeida Monteiro, R. A., da Silva, L. F. F., de Oliveira, E. P., Saldiva, P. H. N., Mauad, T., & Negri, E. M. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14844 · Cited by 592
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Mahallawi, W. H., Khabour, O. F., Zhang, Q., Makhdoum, H. M., & Suliman, B. A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.025 · Cited by 558
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Channappanavar, R., Fehr, A. R., Zheng, J., Wohlford-Lenane, C., Abrahante, J. E., Mack, M., Sompallae, R., McCray, P. B., Meyerholz, D. K., & Perlman, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126363 · Cited by 556
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
Chen, I.-Y., Moriyama, M., Chang, M.-F., & Ichinohe, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00050 · Cited by 547
The role of chemokines in neutrophil biology
Kobayashi, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2853 · Cited by 545
Rapkiewicz, A. V., Mai, X., Carsons, S. E., Pittaluga, S., Kleiner, D. E., Berger, J. S., Thomas, S., Adler, N. M., Charytan, D. M., Gasmi, B., et al. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100434 · Cited by 533
IL-1 stimulates IL-6 production in endothelial cells.
Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E., & Mantovani, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.549 · Cited by 521
Nieto-Torres, J. L., Verdiá-Báguena, C., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Castaño-Rodriguez, C., Fernandez-Delgado, R., Torres, J., Aguilella, V. M., & Enjuanes, L. (2015) · Virology · doi:10.1016/j.virol.2015.08.010 · Cited by 511
COVID-19 spike-host cell receptor GRP78 binding site prediction
Ibrahim, I. M., Abdelmalek, D. H., Elshahat, M. E., & Elfiky, A. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.026 · Cited by 509
Siu, K., Yuen, K., Castano‐Rodriguez, C., Ye, Z., Yeung, M., Fung, S., Yuan, S., Chan, C., Yuen, K., Enjuanes, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802418r · Cited by 502
Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19
Zaid, Y., Puhm, F., Allaeys, I., Naya, A., Oudghiri, M., Khalki, L., Limami, Y., Zaid, N., Sadki, K., Ben El Haj, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317703 · Cited by 496
Self-citation[Management of COVID-19: the Zhejiang experience].
Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., Li, J., Wang, H., Yu, L., Huang, H., et al. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.02.02 · Cited by 452
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Miesbach, W., & Makris, M. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620938149 · Cited by 443
Kang, S., Tanaka, T., Inoue, H., Ono, C., Hashimoto, S., Kioi, Y., Matsumoto, H., Matsuura, H., Matsubara, T., Shimizu, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010229117 · Cited by 330
Exhaled nitric oxide correlates with airway eosinophils in childhood asthma
Warke, T. J. (2002) · Thorax · doi:10.1136/thorax.57.5.383 · Cited by 306
Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
Bester, J., & Pretorius, E. (2016) · Scientific Reports · doi:10.1038/srep32188 · Cited by 305
Mitochondria and microbiota dysfunction in COVID-19 pathogenesis
Saleh, J., Peyssonnaux, C., Singh, K. K., & Edeas, M. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.06.008 · Cited by 305
Sciascia, S., Aprà, F., Baffa, A., Baldovino, S., Boaro, D., Boero, R., Bonora, S., Calcagno, A., Cecchi, I., Cinnirella, G., et al. (2020) · PubMed · Cited by 303
Tocilizumab for the treatment of severe coronavirus disease 2019
Alattar, R., Ibrahim, T. B. H., Shaar, S. H., Abdalla, S., Shukri, K., Daghfal, J. N., Khatib, M. Y., Aboukamar, M., Abukhattab, M., Alsoub, H. A., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25964 · Cited by 259
Wang, W., Ye, L., Ye, L., Li, B., Gao, B., Zeng, Y., Kong, L., Fang, X., Zheng, H., Wu, Z., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.02.007 · Cited by 247
Coagulation and anticoagulation in COVID-19
Hadid, T., Kafri, Z., & Al-Katib, A. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100761 · Cited by 223
Gut microbiota, inflammation, and molecular signatures of host response to infection
Gou, W., Fu, Y., Yue, L., Chen, G.-D., Cai, X., Shuai, M., Xu, F., Yi, X., Chen, H., Zhu, Y., et al. (2021) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.04.002 · Cited by 214
Chu, H., Chan, C.-M., Zhang, X., Wang, Y., Yuan, S., Zhou, J., Au-Yeung, R. K.-H., Sze, K.-H., Yang, D., Shuai, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001897 · Cited by 191
Hou, W., Jin, Y.-H., Kang, H. S., & Kim, B. (2014) · Journal of Virology · doi:10.1128/jvi.00724-14 · Cited by 173
Type I Interferons as Regulators of Lung Inflammation
Makris, S., Paulsen, M. T., & Johansson, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00259 · Cited by 168
Shah, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01021 · Cited by 168
Hot, A., Lenief, V., & Miossec, P. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200468 · Cited by 158
What’s new in the renin-angiotensin system?
Warner, F. J., Smith, A. I., Hooper, N. M., & Turner, A. J. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4240-7 · Cited by 156
Ebihara, N., Matsuda, A., Nakamura, S., Matsuda, H., & Murakami, A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-7956 · Cited by 147
Zhang, X., Wu, K., Wang, D., Yue, X., Song, D., Zhu, Y., & Wu, J. (2007) · Virology · doi:10.1016/j.virol.2007.04.009 · Cited by 141
Dinarello, C. A. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000185500.11080.91 · Cited by 140
Chang, Y., Liu, C. Y. Y., Chiang, B., Chao, Y., & Chen, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7602 · Cited by 136
Sallenave, J., & Guillot, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01229 · Cited by 130
da Costa, L. S., Outlioua, A., Anginot, A., Akarid, K., & Arnoult, D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1579-0 · Cited by 122
Self-citationMa, Q., Li, R., Pan, W., Huang, W., Liu, B., Xie, Y., Wang, Z., Li, C., Jiang, H., Huang, J., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153296 · Cited by 115
Arnaldez, F. I., O'Day, S. J., Drake, C. G., Fox, B. A., Fu, B., Urba, W. J., Montesarchio, V., Weber, J. S., Wei, H., Wigginton, J. M., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000930 · Cited by 96
Cytokine Profiling Plays a Crucial Role in Activating Immune System to Clear Infectious Pathogens
Muñoz‐Carrillo, J. L., Contreras‐Cordero, J. F., Gutiérrez‐Coronado, O., Villalobos‐Gutiérrez, P. T., Ramos-Gracia, L. G., & Hernández-Reyes, V. E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80843 · Cited by 95
IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells
Ryzhakov, G., Lai, C., Blazek, K. D., To, K.-W., Hussell, T., & Udalova, I. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100917 · Cited by 91
A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections
Orlov, M., Wander, P. L., Morrell, E. D., Mikacenic, C. R., & Wurfel, M. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000554 · Cited by 90
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
Mazza, S., Sorce, A., Peyvandi, F., Vecchi, M. L., & Caprioli, F. (2020) · Gut · doi:10.1136/gutjnl-2020-321183 · Cited by 73
Cytokine synergy: An underappreciated contributor to innate anti-viral immunity
Bartee, E., & McFadden, G. (2013) · Cytokine · doi:10.1016/j.cyto.2013.04.036 · Cited by 64
COVID-19 infection in Crohn’s disease under treatment with adalimumab
Tursi, A., Angarano, G., Monno, L., Saracino, A., Signorile, F., Ricciardi, A., & Papa, A. (2020) · Gut · doi:10.1136/gutjnl-2020-321240 · Cited by 56
Microbiota-dependent signals are required to sustain TLR-mediated immune responses
Weaver, L. K., Minichino, D. E., Biswas, C., Chu, N., Lee, J., Bittinger, K. L., Albeituni, S., Nichols, K. E., & Behrens, E. M. (2019) · JCI Insight · doi:10.1172/jci.insight.124370 · Cited by 55
TNF‐α‐induces airway hyperresponsiveness to cholinergic stimulation in guinea pig airways
Makwana, R., Gozzard, N., Spina, D., & Page, C. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01675.x · Cited by 33
COVID ‐19 in an elderly patient treated with secukinumab
Lernia, V. G. D., Bombonato, C., & Motolese, A. (2020) · Dermatologic Therapy · doi:10.1111/dth.13580 · Cited by 20
Inborn Errors of Type I IFN Immunity in Patients With Life-Threatening COVID-19
Orange, J. S. (2021) · PEDIATRICS · doi:10.1542/peds.2021-053843bbbbb · Cited by 19
The different faces of the NLRP3 inflammasome in cutaneous Leishmaniasis: A review
Kihel, A., Hammi, I., Darif, D., Lemrani, M., Riyad, M., Guessous, F., & Akarid, K. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155248 · Cited by 16
Self-citationMahmud-Al-Rafat, A., Asim, M. M. H., Taylor-Robinson, A. W., Majumder, A., Muktadir, A., Muktadir, H., Karim, M., Khan, I., Ahasan, M. M., & Billah, M. M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155228 · Cited by 10
Cited by
COVID-19 infection: an overview on cytokine storm and related interventions
Montazersaheb, S., Hosseiniyan Khatibi, S. M., Hejazi, M. S., Tarhriz, V., Farjami, A., Ghasemian Sorbeni, F., Farahzadi, R., & Ghasemnejad, T. (2022) · Virology Journal · doi:10.1186/s12985-022-01814-1 · Cited by 610
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Metadata
- Authors
- Darif, D., Hammi, I., Kihel, A., El Idrissi Saik, I., Guessous, F., & Akarid, K.
- Venue
- Microbial Pathogenesis
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 153
- Pages
- 104799
- ISSN
- 0882-4010 (ISSN-L)
- OpenAlex
- W3130206057
- Cited by
- 326
- References
- 101
- FWCI
- 20.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.